Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01030081Phase 4Completed
Phase 4, randomised, open-label trial of amlodipine in hypertension (HTN) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Change from baseline in mean systolic blood pressure during morning hours (4 am to 8 am) at 8 weeks. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01030081.